Table 4. Selection criteria for ovarian tissue cryopreservation.

1. Age below 35 years (flexible depending on AMH level and biological age)

2. A high risk of premature ovarian failure (>50%) gonadotoxic

3. A realistic chance of surviving for 5 years

4. No previous chemotherapy or radiotherapy if aged 15 years or older at diagnosis, but mild, non-gonadotoxic chemotherapy is acceptable if younger than 15 years

5. No disseminated disease

6. No contraindications against operation or anaesthesia

7. Informed consent (parent and patient when possible)

AMH, anti-Müllerian hormone.